● Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors

Condition: Skin Cancer · Cutaneous Tumor · Cutaneous Metastasis · Sponsor: Alpha Tau Medical LTD.

PhaseNA

Planned participants80

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for Malignant Cutaneous Tumors

This description comes directly from the study's public registry record.

Talk to the study team

Liron Dimnik · +972-2-373-7000 · LironD@alphatau.com

Amnon Gat · Amnong@alphatau.com

Always discuss trial participation with your own doctor first.

Locations (2)

CHU Grenoble Alpes	Grenoble, France	Recruiting
Centre Léon Bérard	Lyon, France	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04068155